COVID-19: WHO Approves China’s Sinovac Vaccine

WHO Scientists Study Omicron COVID Variant
WhatsApp
Facebook
Twitter
Telegram
LinkedIn
Print

The World Health Organization has announced that it has approved the Sinovac COVID-19 vaccine produced in China for emergency use.

Africa Daily News, New York gathered that the development was contained in a statement issued yesterday by the UN health agency.

The agency assured counties that the vaccine met the international standard and is safe for use against the deadly coronavirus.

Read Also: AstraZeneca Briefs Nigeria On COVID-19 Vaccine Fears

‘WHO today validated the Sinovac-CoronaVac Covid-19 vaccine for emergency use, giving countries, funders, procuring agencies, and communities the assurance that it meets international standards for safety, efficacy, and manufacturing.

Sinovac is the second COVID-19 vaccine made in the country with the WHO’s approval.

Africa Daily News, New York reports that WHO had on May 7, granted emergency approval for a COVID vaccine made by Chinese state-owned company Sinopharm.

It was the first vaccine developed by a non-Western country to get WHO backing.

 

AFRICA DAILY NEWS, NEW YORK

WhatsApp
Facebook
Twitter
Telegram
LinkedIn
Print